About Us

We are a "Research as a service" consulting firm that is focused on the field of immunotherapies and their applications in oncology.

Traditionally the treatment of cancer has required some form of chemotherapy, radiation and surgical resection of the tumor. However immunotherapy is a rabidly growing field in which either the host immune system is updated or supplemented with the help of either modified immune cells (Chimeric antigen receptor T cells) or by adding agents like PD-1 and PD-L1 inhibitors, However this promising new field of therapy has limited success and may not be right for everyone. 

We are constantly doing realtime analysis of multiple published studies as well as real world data combined with clinical expertise of key opinion leaders to validate trends as well as identify gap areas to fulfill the promise of better treatments for cancer.